GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » HealthEquity Inc (NAS:HQY) » Definitions » Change In Receivables
中文

HealthEquity (HealthEquity) Change In Receivables : $-8.1 Mil (TTM As of Jan. 2024)


View and export this data going back to 2014. Start your Free Trial

What is HealthEquity Change In Receivables?

HealthEquity's change in receivables for the quarter that ended in Jan. 2024 was $-8.7 Mil. It means HealthEquity's Accounts Receivable increased by $8.7 Mil from Oct. 2023 to Jan. 2024 .

HealthEquity's change in receivables for the fiscal year that ended in Jan. 2024 was $-8.1 Mil. It means HealthEquity's Accounts Receivable increased by $8.1 Mil from Jan. 2023 to Jan. 2024 .

HealthEquity's Accounts Receivable for the quarter that ended in Jan. 2024 was $104.9 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. HealthEquity's Days Sales Outstanding for the three months ended in Jan. 2024 was 36.48.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. HealthEquity's liquidation value for the three months ended in Jan. 2024 was $-646.1 Mil.


HealthEquity Change In Receivables Historical Data

The historical data trend for HealthEquity's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HealthEquity Change In Receivables Chart

HealthEquity Annual Data
Trend Jan15 Jan16 Jan17 Jan18 Jan19 Jan20 Jan21 Jan22 Jan23 Jan24
Change In Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only -4.03 -0.41 -11.20 -9.57 -8.06

HealthEquity Quarterly Data
Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
Change In Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -9.12 -1.58 5.83 -3.60 -8.71

HealthEquity Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Jan. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-8.1 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


HealthEquity  (NAS:HQY) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

HealthEquity's Days Sales Outstanding for the quarter that ended in Jan. 2024 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=104.893/262.387*91
=36.48

2. In Ben Graham's calculation of liquidation value, HealthEquity's accounts receivable are only considered to be worth 75% of book value:

HealthEquity's liquidation value for the quarter that ended in Jan. 2024 is calculated as:

Liquidation Value
=Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=403.979-1128.769+0.75 * 104.893+0.5 * 0
=-646.1

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


HealthEquity Change In Receivables Related Terms

Thank you for viewing the detailed overview of HealthEquity's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.


HealthEquity (HealthEquity) Business Description

Traded in Other Exchanges
Address
15 West Scenic Pointe Drive, Suite 100, Draper, UT, USA, 84020
HealthEquity Inc provides solutions that allow consumers to make healthcare saving and spending decisions. Its technology allows customers to see their tax-advantaged healthcare savings, compare treatment options and pricing, pay healthcare bills, receive benefit information, and earn wellness incentives. The firm primarily partners with health plans and employers and serves as the custodian of its customers' health savings accounts (HSAs). HealthEquity also engages in reimbursement arrangements and offers healthcare incentives to its members. In addition, the company provides investment advisory services to customers whose account balances exceed a certain threshold. HealthEquity generates its revenue in the United States.
Executives
Delano Ladd officer: Executive VP, GC & Corp. Secy. 15W. SCENIC POINTE DR., SUITE 100, DRAPER UT 84020
Ian Sacks director TOWERBROOK CAP., PARK AVENUE TOWER, 65 E 55TH ST., 27TH FLOOR, NEW YORK NY 10022
Elimelech Rosner officer: EVP, Chief Technology Officer 5196 BELMORE COURT, SUWANEE GA 30024
Stephen Neeleman director, officer: Founder and Vice Chairman 15 W. SCENIC POINTE DR., STE. 100, DRAPER UT 84020
Tyson D. Murdock officer: EVP & CFO 2275 S. 2200 E., SALT LAKE CITY UT 84109
Jon Kessler director, officer: President and CEO 15 W. SCENIC POINTE DR., STE. 100, DRAPER UT 84020
Frank Corvino director GREENWICH HOSPITAL, 5 PERRYRIDGE ROAD, GREENWICH CT 06830
Larry L Trittschuh officer: EVP Chief Security Officer 1051 RUNNYMEDE ROAD, OAKWOOD OH 45419
James M Lucania officer: EVP & CFO 101 WOLF DRIVE, THOROFARE NJ 08086
Gayle Furgurson Wellborn director 123 TORRENCE CHAPEL ROAD, MOORESVILLE NC 28117
Debra Charlotte Mccowan director 1436 CABRILLO AVENUE, BURLINGAME CA 94010
Paul Black director 400 WOOD ROAD, BRAINTREE MA 02184
Edward Bloomberg officer: Chief Operating Officer 13207 WINDSOR STREET, LEAWOOD KS 66209
Rajesh Natarajan director 7500 DALLAS PARKWAY, SUITE 700, PLANO TX 75024
Evelyn S Dilsaver director C/O LONGS DRUG STORES CORPORATION, 141 NORTH CIVIC DRIVE, WALNUT CREEK CA 94596